identifi
viral
aetiolog
adult
patient
sever
acut
respiratori
infect
sari
admit
sentinel
surveil
institut
crosssect
studi
conduct
microarray
molecular
techniqu
viral
identif
use
nasopharyng
sampl
adult
patient
submit
surveil
system
descript
clinic
featur
relev
clinic
outcom
mortal
need
critic
care
use
mechan
ventil
hospit
stay
obtain
respiratori
infect
requir
hospit
admiss
surveil
centr
colombia
ninetyon
adult
patient
acut
respiratori
infect
femal
viral
identif
intens
care
unit
admiss
hospit
stay
mortal
viral
identif
achiev
patient
comorbid
frequent
identifi
mainli
involv
chronic
pulmonari
diseas
pregnanc
influenza
bocaviru
adenoviru
identifi
case
respect
admiss
intens
care
unit
occur
case
mechan
ventil
requir
averag
hospit
stay
day
mortal
antibiot
empir
use
patient
preval
viral
aetiolog
sari
studi
high
advers
clinic
outcom
intens
care
requir
high
mortal
descript
crosssect
studi
perform
determin
preval
virus
adult
patient
sari
less
day
evolut
use
microarray
techniqu
studi
also
describ
clinic
characterist
outcom
mortal
viru
respiratori
infect
plo
one
acut
respiratori
infect
one
main
caus
hospit
death
worldwid
although
identif
aetiolog
agent
achiev
major
case
instead
infect
treat
empir
often
success
antimicrobi
therapi
nonetheless
role
virus
aetiolog
infect
becom
clear
especi
pandem
new
influenza
subtyp
presenc
viru
impli
either
benign
clinic
cours
system
inflammatori
respons
complic
absent
due
implic
public
health
effort
reinforc
improv
epidemiolog
surveil
respiratori
infect
increas
initi
countri
develop
surveil
system
follow
case
influenzalik
ill
sever
acut
respiratori
infect
sari
clinic
diagnos
among
patient
fever
cough
sore
throat
difficulti
breath
need
hospit
main
aim
surveil
provid
inform
circul
virus
suscept
influenza
avail
antivir
also
promot
defin
vaccin
need
differ
popul
true
impact
viral
infect
aetiolog
acut
respiratori
diseas
requir
hospit
unknown
aim
studi
identifi
viral
aetiolog
hospit
adult
patient
sari
describ
characterist
clinic
outcom
among
patient
studi
perform
colombia
capit
citi
locat
and
south
america
near
equat
metr
sea
level
total
tertiari
care
hospit
perform
sentinel
surveil
sari
particip
studi
hospit
forward
respiratori
sampl
patient
sari
district
health
depart
sari
defin
respiratori
infect
possibl
viral
andor
bacteri
origin
requir
inpati
manag
clinic
present
fever
less
day
onset
higher
short
breath
cough
hypoxia
system
compromis
system
inflammatori
respons
syndrom
organ
failur
depend
symptom
sever
sampl
taken
via
nasopharyng
aspir
swab
sampl
sent
togeth
requir
basic
epidemiolog
data
collect
form
epidemiolog
surveil
system
sistema
de
vigilancia
nacionalsivigila
sampl
sent
viral
transport
medium
public
health
laboratori
district
health
depart
store
refriger
intend
purpos
need
intens
care
use
mechan
ventil
length
hospit
stay
inclus
criteria
consist
patient
year
age
provid
respiratori
sampl
one
hospit
perform
sentinel
surveil
patient
incomplet
medic
record
sampl
institut
exclud
follow
research
ethic
committe
particip
institut
approv
studi
except
one
institut
request
written
inform
consent
access
medic
record
cardioinfantil
instituto
de
written
consent
obtain
particip
proxi
case
death
institut
patient
found
respond
refus
provid
written
consent
written
inform
consent
case
request
obtain
kept
universidad
nacion
de
colombia
total
nasopharyng
aspir
swab
sampl
taken
adult
patient
hospit
sampl
randomli
select
inclus
criteria
patient
older
year
age
sari
report
surveil
system
year
sampl
size
calcul
found
respiratori
sampl
need
preval
poorest
accept
result
power
confid
level
howev
molecular
test
could
process
sampl
increas
patient
subsequ
medic
record
review
approv
authoris
research
ethic
committe
institut
inform
gather
hospit
microarray
diagnost
assay
use
clart
pneumovir
equip
genomica
madrid
spain
use
identifi
virus
involv
assay
detect
characteris
virus
frequent
caus
respiratori
symptom
human
follow
virus
analys
respiratori
syncyti
viru
rsv
b
influenza
pdm
b
c
viru
parainfluenza
viru
subtyp
metapneumoviru
b
adenoviru
enteroviru
rhinoviru
coronaviru
subtyp
bocaviru
kit
amplifi
specif
fragment
viral
genom
via
revers
transcript
polymeras
chain
reaction
pcr
via
pcr
hybridis
detect
use
specif
captur
probe
follow
variabl
collect
patient
medic
histori
accord
intern
definit
age
gender
comorbid
chronic
obstruct
pulmonari
diseas
copd
diabet
mellitu
heart
failur
inclus
criteria
took
account
system
inflammatori
respons
syndrom
sir
defin
heart
rate
beat
per
minut
breath
rate
breath
per
minut
leukocytosi
cell
per
millilitr
leukopenia
fewer
cell
per
millilitr
fever
pneumonia
among
sari
patient
diagnos
radiolog
find
consolid
alveolar
infiltr
confus
urea
respiratori
rate
blood
pressur
curb
score
pneumonia
appli
use
criteria
age
greater
equal
year
impair
conscious
blood
urea
nitrogen
bun
mgdl
breath
rate
breath
per
minut
systol
arteri
pressur
mmhg
diastol
pressur
mmhg
addit
sever
pneumonia
consid
among
patient
compli
follow
major
minor
criteria
american
thorac
societyinfecti
diseas
societi
america
atsidsa
shock
need
mechan
ventil
thrombocytopenia
platelet
arteri
oxygen
partial
pressur
fraction
inspir
oxygen
ratio
pao
fio
ratio
multilobar
compromis
impair
conscious
leukopenia
bun
mgdl
shock
also
consid
systol
arteri
pressur
mmhg
diastol
arteri
pressur
mmhg
moder
oxygen
impair
defin
pao
fio
mmhg
mmhg
sever
oxygen
impair
defin
index
less
equal
mmhg
institut
identifi
viral
antigen
follow
institut
protocol
perform
interpret
test
hospit
colonis
airway
defin
presenc
microorgan
gram
test
cultur
airway
gram
test
sputum
cultur
respiratori
sampl
perform
base
clinic
decis
made
doctor
institut
viral
coinfect
diagnosi
made
differ
virus
identifi
sampl
chisquar
test
fisher
exact
test
use
compar
categor
variabl
comparison
continu
variabl
perform
either
student
test
mannwhitney
u
test
casebycas
basi
variabl
analysi
perform
use
stata
ver
p
valu
less
consid
signific
odd
ratio
correspond
confid
interv
ci
use
analys
outcom
sampl
respiratori
secret
collect
sentinel
surveil
system
patient
year
age
randomis
sampl
case
sari
select
respiratori
sampl
fig
medic
histori
patient
sari
report
surveil
system
examin
histori
obtain
bogota
hospit
accord
follow
distribut
san
rafael
univers
hospit
clinic
cardioinfantil
suba
hospit
el
tunal
hospit
santa
clara
hospit
san
ignacio
univers
hospit
occident
de
kennedi
hospit
patient
show
diseas
progress
beyond
day
dismiss
final
analysi
fig
patient
includ
analysi
femal
patient
averag
age
year
rang
year
tabl
show
frequent
comorbid
identifi
averag
length
diseas
progress
day
minimum
durat
hour
maximum
durat
day
tabl
radiograph
abnorm
observ
patient
follow
radiolog
find
chest
imag
describ
medic
histori
order
frequenc
patient
interstiti
infiltr
alveolar
infiltr
consolid
multilobar
compromis
pleural
effus
admiss
pleural
effus
found
patient
alveolar
infiltr
patient
interstiti
infiltr
among
sari
patient
treat
antibiot
patient
receiv
antibiot
averag
antibiot
per
patient
antibiot
start
median
day
admiss
rang
day
ci
day
betalactam
group
frequent
use
oseltamivir
use
case
patient
minimum
durat
day
maximum
durat
day
averag
durat
day
oseltamivir
start
median
day
admiss
rang
day
ci
day
least
one
viru
identifi
patient
tabl
influenza
viru
common
isol
patient
influenza
influenza
b
tabl
parainfluenza
viru
subtyp
identifi
five
case
piv
one
case
piv
group
one
viral
infect
influenza
bocaviru
identifi
throughout
year
though
case
influenza
commonli
found
may
august
septemb
case
bocaviru
commonli
found
june
novemb
influenza
b
identifi
second
semest
two
case
influenza
seen
may
adenoviru
seen
raini
season
april
may
august
novemb
case
metapneumoviru
parainfluenza
rsv
seen
first
semest
specif
april
may
two
case
coronaviru
identifi
may
fig
patient
without
viral
detect
differ
term
comorbid
except
frequenc
diabet
mellitu
diabet
detect
patient
viral
detect
patient
without
viral
detect
fisher
exact
test
p
patient
pneumonia
viru
identifi
patient
sever
pneumonia
diagnos
patient
without
viral
detect
patient
viral
detect
signific
differ
observ
group
without
viral
detect
regard
sir
neutropenia
hospit
shock
patient
sari
histori
copd
virus
identifi
viral
coinfect
virus
distribut
follow
case
bocaviru
adenoviru
influenza
parainfluenza
rsv
metapneumoviru
coronaviru
rhinoviru
patient
activ
smoker
viral
infect
bocaviru
frequent
isol
viru
regard
complic
pleural
effus
develop
patient
without
viral
identif
patient
viral
identif
close
thoracotomi
requir
patient
without
viral
identif
patient
viral
identif
inpati
infect
present
patient
without
viral
identif
respect
underli
diseas
complic
found
patient
without
viral
identif
patient
viral
identif
differ
statist
signific
patient
chronic
pneumopathi
show
complic
underli
patholog
vs
ci
total
patient
die
howev
two
case
includ
either
inadequ
sampl
pcr
pcr
amplif
thu
outcom
analysi
perform
patient
mortal
report
case
group
without
viral
identif
case
group
viral
identif
p
ci
tabl
mechan
ventil
requir
patient
intervent
invas
patient
noninvas
patient
invas
noninvas
patient
outcom
occur
among
patient
without
viral
identif
patient
viral
identif
p
ci
averag
length
mechan
ventil
day
minimum
day
maximum
day
thirtynin
patient
admit
intens
care
unit
icu
unsuit
sampl
nonamplifi
pcr
result
group
without
isol
viru
group
isol
viru
p
ci
one
case
viral
identif
readmit
unit
identif
influenza
subtyp
averag
length
icu
stay
day
rang
day
group
isol
viru
averag
icu
stay
day
rang
day
group
without
isol
viru
averag
stay
day
rang
day
p
averag
hospit
stay
sari
group
day
rang
day
averag
stay
day
patient
without
viru
respect
p
among
patient
without
viru
hospit
stay
vari
day
patient
viru
hospit
stay
vari
day
patient
viral
infect
group
die
bocaviru
isol
influenza
isol
case
influenza
metapneumoviru
isol
rsv
isol
patient
bocaviru
isol
die
death
occur
influenza
identifi
metapneumoviru
identifi
rsv
identifi
among
patient
viral
identif
die
viral
infect
virus
p
ci
fewer
one
viru
detect
statist
signific
differ
observ
outcom
remain
patient
mix
viral
infect
confirm
higher
morbid
patient
virus
isol
diagnosi
acut
respiratori
infect
common
appar
easi
perform
howev
determin
infect
causal
agent
complex
current
diagnost
tool
limit
rare
avail
primari
health
care
centr
even
hospit
much
world
role
virus
preval
matter
debat
discuss
find
vari
worldwid
result
studi
new
zealand
spain
recent
unit
kingdom
report
preval
rate
respect
studi
virus
identifi
frequent
causal
agent
sari
requir
hospit
case
show
high
rate
viral
coinfect
high
degre
morbid
prolong
hospit
stay
frequent
need
icu
manag
mechan
ventil
definit
sari
use
studi
great
util
epidemiolog
surveil
perspect
known
syndrom
surveil
surveil
syndrom
nonetheless
result
report
demonstr
clinic
relev
potenti
util
field
appear
identifi
potenti
sever
patient
high
complic
rate
thu
definit
routin
use
consid
perform
clinic
duti
furthermor
current
challeng
epidemiolog
surveil
viral
respiratori
tract
infect
includ
earli
fast
identif
aetiolog
agent
especi
begin
outbreak
optim
time
manag
larg
number
sampl
studi
suggest
molecular
technolog
make
possibl
close
follow
circul
virus
group
patient
contrast
epidemiolog
definit
use
index
pneumonia
use
score
gener
hospit
none
score
icu
use
criteria
find
contrast
high
number
patient
requir
icu
care
agre
find
literatur
appli
scale
case
viral
pneumonia
influenza
subtyp
pandem
result
demonstr
low
valu
detect
either
sever
need
icu
admiss
patient
viral
pneumonia
find
repres
mark
differ
sever
stratif
influenzarel
pneumonia
pneumonia
caus
aetiolog
agent
indic
import
clinic
judgement
scenario
applic
scale
noninfluenza
viral
pneumonia
yet
assess
moreov
recent
multicentr
studi
adult
radiograph
confirm
pneumonia
shown
virus
commonli
identifi
pathogen
human
rhinoviru
influenza
viru
frequent
found
streptococcu
pneumonia
togeth
virus
repres
quarter
patient
half
pathogen
identifi
mortal
rate
rel
high
patient
without
communityacquir
pneumonia
studi
perform
unit
state
report
low
mortal
rate
patient
hospit
viral
infect
nonetheless
bacteri
coinfect
increas
morbid
mortal
variabl
consid
patient
countri
mark
season
report
correl
influenza
high
mortal
due
respiratori
infect
usual
relat
communityacquir
pneumonia
season
pattern
acut
respiratori
infect
especi
viral
infect
due
influenza
depend
temperatur
humid
host
factor
serum
vitamin
level
colombia
locat
tropic
thu
lack
season
howev
studi
confirm
infect
especi
caus
influenza
rsv
infect
increas
raini
season
countri
latitud
pattern
show
import
epidemiolog
surveil
especi
season
virus
circul
may
increas
control
prevent
strategi
time
vaccin
techniqu
base
identifi
nucleic
acid
use
studi
obtain
rapid
precis
result
diagnos
viral
infect
order
provid
appropri
manag
medic
care
limit
inform
diagnost
util
new
test
studi
sultankulova
et
al
compar
viral
isol
influenza
dna
microarray
technolog
show
higher
sensit
similar
specif
realtim
pcr
howev
anoth
studi
microarray
kit
use
studi
show
high
specif
low
sensit
clinic
scenario
atyp
pneumonia
studi
japan
use
near
patient
autom
microarray
technolog
show
higher
sensit
specif
compar
immunochromatograph
antigen
detect
gold
standard
use
viru
isol
also
quicker
result
children
infect
influenza
rsv
recent
multicentr
studi
unit
state
use
realtim
pcr
technolog
abl
precis
reproduc
detect
adenoviru
infect
group
children
adult
respiratori
infect
increas
possibl
establish
clear
diagnosi
taken
togeth
use
molecular
technolog
diagnosi
viral
infect
improv
detect
identifi
case
antibiot
use
might
inadequ
use
antibiot
acut
respiratori
infect
indiscrimin
excess
accord
worldwid
literatur
employ
half
respiratori
infect
studi
determin
case
treat
antibiot
although
infect
viral
origin
addit
strategi
measur
procalcitonin
identifi
patient
would
benefit
antibiot
therapi
studi
sever
limit
although
multicentr
design
inform
gather
one
citi
colombia
one
import
limit
retrospect
studi
thu
possibl
control
viral
bacteri
sampl
limit
access
relev
data
previou
influenza
pneumococc
vaccin
histori
comorbid
measur
sampl
size
smaller
expect
although
preval
viral
infect
higher
expect
togeth
limit
lead
difficulti
establish
signific
comparison
among
group
appropri
assess
impact
comorbid
bacteri
coinfect
outcom
especi
relat
role
pneumococcu
limit
includ
difficulti
defin
actual
role
certain
virus
bocaviru
rhinoviru
respiratori
infect
also
detect
asymptomat
patient
accord
descript
literatur
empir
use
antibiot
case
without
use
addit
tool
confirm
bacteri
infect
also
limit
